Moleculin Biotech Stock Price History
| MBRX Stock | USD 0.67 0.04 6.35% |
Below is the normalized historical share price chart for Moleculin Biotech extending back to June 02, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Moleculin Biotech stands at 0.67, as last reported on the 1st of August, with the highest price reaching 0.69 and the lowest price hitting 0.59 during the day.
If you're considering investing in Moleculin Stock, it is important to understand the factors that can impact its price. At this stage we consider Moleculin Stock to be dangerous. Moleculin Biotech has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Moleculin Biotech, which you can use to evaluate the volatility of the firm. Please verify Moleculin Biotech's Risk Adjusted Performance of 0.0127, mean deviation of 6.78, and Downside Deviation of 11.82 to check out if the risk estimate we provide is consistent with the expected return of 0.0711%.
At this time, Moleculin Biotech's Common Stock Total Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 3.6 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 5.7 M in 2025. . At this time, Moleculin Biotech's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.03 in 2025, whereas Price Earnings Ratio is likely to drop (0.28) in 2025. Moleculin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of June 2016 | 200 Day MA 1.3982 | 50 Day MA 0.6348 | Beta 1.379 |
Moleculin | Build AI portfolio with Moleculin Stock |
Sharpe Ratio = 0.0061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | MBRX |
| Negative Returns |
Estimated Market Risk
| 11.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Moleculin Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Moleculin Biotech by adding Moleculin Biotech to a well-diversified portfolio.
Moleculin Biotech Stock Price History Chart
There are several ways to analyze Moleculin Stock price data. The simplest method is using a basic Moleculin candlestick price chart, which shows Moleculin Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | May 12, 2025 | 1.08 |
| Lowest Price | June 20, 2025 | 0.27 |
Moleculin Biotech August 1, 2025 Stock Price Synopsis
Various analyses of Moleculin Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Moleculin Stock. It can be used to describe the percentage change in the price of Moleculin Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Moleculin Stock.| Moleculin Biotech Price Rate Of Daily Change | 1.06 | |
| Moleculin Biotech Price Daily Balance Of Power | 0.40 | |
| Moleculin Biotech Price Action Indicator | 0.05 | |
| Moleculin Biotech Accumulation Distribution | 309,275 |
Moleculin Biotech August 1, 2025 Stock Price Analysis
Moleculin Stock Price History Data
The price series of Moleculin Biotech for the period between Sat, May 3, 2025 and Fri, Aug 1, 2025 has a statistical range of 0.81 with a coefficient of variation of 33.75. The daily prices for the period are spread out with arithmetic mean of 0.73. The median price for the last 90 days is 0.71. The company underwent 1:15 stock split on 22nd of March 2024. Moleculin Biotech issued dividends to stockholders on 2021-02-01.| Open | High | Low | Close | Volume | ||
08/01/2025 | 0.60 | 0.69 | 0.59 | 0.67 | 2,133,995 | |
07/31/2025 | 0.67 | 0.71 | 0.61 | 0.63 | 2,694,873 | |
| 07/30/2025 | 0.75 | 0.75 | 0.67 | 0.71 | 5,227,648 | |
07/29/2025 | 0.64 | 0.72 | 0.57 | 0.71 | 18,532,359 | |
07/28/2025 | 0.58 | 0.63 | 0.53 | 0.55 | 3,065,290 | |
07/25/2025 | 0.63 | 0.63 | 0.56 | 0.57 | 2,592,115 | |
07/24/2025 | 0.68 | 0.72 | 0.63 | 0.64 | 1,908,705 | |
07/23/2025 | 0.79 | 0.79 | 0.69 | 0.71 | 2,265,930 | |
| 07/22/2025 | 0.80 | 0.85 | 0.76 | 0.78 | 1,226,756 | |
07/21/2025 | 0.83 | 0.86 | 0.74 | 0.80 | 2,553,453 | |
07/18/2025 | 0.85 | 0.96 | 0.79 | 0.80 | 4,459,966 | |
| 07/17/2025 | 0.68 | 0.87 | 0.66 | 0.84 | 9,596,457 | |
07/16/2025 | 0.63 | 0.68 | 0.62 | 0.64 | 2,434,905 | |
07/15/2025 | 0.68 | 0.73 | 0.61 | 0.63 | 3,582,798 | |
| 07/14/2025 | 0.53 | 0.71 | 0.50 | 0.63 | 9,941,250 | |
07/11/2025 | 0.52 | 0.58 | 0.50 | 0.55 | 2,962,228 | |
07/10/2025 | 0.56 | 0.57 | 0.51 | 0.53 | 3,416,121 | |
| 07/09/2025 | 0.63 | 0.67 | 0.53 | 0.57 | 34,123,719 | |
07/08/2025 | 0.44 | 0.70 | 0.43 | 0.52 | 92,491,758 | |
07/07/2025 | 0.34 | 0.40 | 0.33 | 0.39 | 4,513,344 | |
| 07/03/2025 | 0.35 | 0.36 | 0.34 | 0.34 | 1,255,133 | |
07/02/2025 | 0.32 | 0.36 | 0.31 | 0.35 | 2,893,100 | |
07/01/2025 | 0.30 | 0.33 | 0.29 | 0.33 | 2,374,600 | |
06/30/2025 | 0.31 | 0.31 | 0.29 | 0.30 | 2,565,000 | |
06/27/2025 | 0.31 | 0.32 | 0.30 | 0.31 | 4,263,100 | |
06/26/2025 | 0.30 | 0.42 | 0.29 | 0.32 | 32,669,551 | |
06/25/2025 | 0.30 | 0.30 | 0.28 | 0.29 | 4,605,789 | |
06/24/2025 | 0.28 | 0.31 | 0.28 | 0.30 | 22,054,240 | |
| 06/23/2025 | 0.27 | 0.28 | 0.26 | 0.27 | 5,787,433 | |
| 06/20/2025 | 0.27 | 0.34 | 0.25 | 0.27 | 16,842,131 | |
| 06/18/2025 | 0.68 | 0.73 | 0.55 | 0.58 | 1,306,444 | |
06/17/2025 | 0.68 | 0.68 | 0.64 | 0.67 | 253,952 | |
| 06/16/2025 | 0.63 | 0.69 | 0.63 | 0.69 | 393,329 | |
06/13/2025 | 0.65 | 0.67 | 0.63 | 0.64 | 306,984 | |
06/12/2025 | 0.68 | 0.69 | 0.66 | 0.67 | 496,629 | |
06/11/2025 | 0.66 | 0.70 | 0.66 | 0.69 | 437,580 | |
06/10/2025 | 0.67 | 0.69 | 0.65 | 0.66 | 715,434 | |
06/09/2025 | 0.71 | 0.71 | 0.65 | 0.67 | 686,079 | |
06/06/2025 | 0.65 | 0.72 | 0.63 | 0.67 | 786,611 | |
| 06/05/2025 | 0.69 | 0.71 | 0.64 | 0.69 | 1,789,860 | |
06/04/2025 | 0.64 | 0.80 | 0.62 | 0.67 | 11,105,310 | |
06/03/2025 | 0.87 | 0.89 | 0.83 | 0.84 | 221,931 | |
06/02/2025 | 0.87 | 0.93 | 0.85 | 0.91 | 277,704 | |
05/30/2025 | 0.89 | 0.91 | 0.87 | 0.87 | 107,369 | |
05/29/2025 | 0.89 | 0.92 | 0.89 | 0.91 | 124,946 | |
05/28/2025 | 0.92 | 0.92 | 0.87 | 0.89 | 130,111 | |
05/27/2025 | 0.93 | 0.94 | 0.86 | 0.89 | 362,751 | |
05/23/2025 | 0.94 | 0.96 | 0.92 | 0.95 | 104,173 | |
05/22/2025 | 0.96 | 0.97 | 0.91 | 0.94 | 281,728 | |
05/21/2025 | 0.97 | 0.98 | 0.95 | 0.97 | 100,337 | |
05/20/2025 | 1.00 | 1.00 | 0.92 | 0.98 | 256,048 | |
05/19/2025 | 0.97 | 1.00 | 0.95 | 0.99 | 298,218 | |
05/16/2025 | 0.92 | 0.96 | 0.91 | 0.94 | 205,469 | |
05/15/2025 | 0.98 | 0.99 | 0.89 | 0.91 | 638,863 | |
| 05/14/2025 | 1.02 | 1.05 | 0.94 | 0.99 | 418,732 | |
05/13/2025 | 1.06 | 1.10 | 1.05 | 1.07 | 280,231 | |
05/12/2025 | 1.13 | 1.14 | 1.01 | 1.08 | 2,394,056 | |
05/09/2025 | 1.02 | 1.12 | 1.00 | 1.05 | 305,575 | |
05/08/2025 | 1.00 | 1.02 | 0.99 | 1.01 | 136,570 | |
05/07/2025 | 0.99 | 1.02 | 0.99 | 1.00 | 79,899 | |
05/06/2025 | 1.01 | 1.04 | 0.99 | 1.02 | 241,333 |
About Moleculin Biotech Stock history
Moleculin Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moleculin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moleculin Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moleculin Biotech stock prices may prove useful in developing a viable investing in Moleculin Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.4 M | 3.6 M | |
| Net Loss | -14.3 M | -15 M |
Moleculin Biotech Stock Technical Analysis
Moleculin Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Moleculin Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Moleculin Biotech's price direction in advance. Along with the technical and fundamental analysis of Moleculin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moleculin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0127 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (1.92) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0788 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.